di(dansyl)cystine has been researched along with methyl methanesulfonate in 1 studies
*Methyl Methanesulfonate: An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. [MeSH]
*Methyl Methanesulfonate: An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. [MeSH]
| Studies (di(dansyl)cystine) | Trials (di(dansyl)cystine) | Recent Studies (post-2010) (di(dansyl)cystine) | Studies (methyl methanesulfonate) | Trials (methyl methanesulfonate) | Recent Studies (post-2010) (methyl methanesulfonate) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 2,461 | 0 | 394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daly, TJ; Matthews, KS; Olson, JS | 1 |
1 other study(ies) available for di(dansyl)cystine and methyl methanesulfonate
| Article | Year |
|---|---|
Formation of mixed disulfide adducts at cysteine-281 of the lactose repressor protein affects operator and inducer binding parameters.
Topics: Cysteine; Cystine; Dansyl Compounds; Disulfides; Dithionitrobenzoic Acid; Escherichia coli; Isopropyl Thiogalactoside; Kinetics; Methyl Methanesulfonate; Nitrobenzoates; Operator Regions, Genetic; Protein Binding; Repressor Proteins; Transcription Factors | 1986 |